{"DataElement":{"publicId":"3261558","version":"1","preferredName":"Progesterone Receptor Percentage Immunohistochemistry Stain Minimum Intensity Score","preferredDefinition":"The score assigned to the minimum Progesterone Recptor Immunohistochemistry stain intensity used to determine a positive finding.","longName":"2651986v1.0:3261487v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2651986","version":"1","preferredName":"Progesterone Receptor Percentage Intensity Stain Description","preferredDefinition":"information related to the description or status of progesterone receptors, specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone, based on percentage and intensity of stained cells.","longName":"PGR_PER_INT_STA_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2542381","version":"1","preferredName":"Progesterone Receptor","preferredDefinition":"Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.","longName":"C17075","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor","conceptCode":"C17075","definition":"Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2251187B-F09C-07DF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-11-15","modifiedBy":"ONEDATA","dateModified":"2006-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2419206","version":"1","preferredName":"Percentage Intensity Stain Description ","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:The degree or magnitude of strength, energy, or feeling.:a dye or other coloring material that is used in microscopy to make structures visible.:Description; a statement that represents something in words.","longName":"C25613:C25539:C0038128:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stain","conceptCode":"C0038128","definition":"a dye or other coloring material that is used in microscopy to make structures visible.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0307659E-EFB3-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"ONEDATA","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32AF12F3-6096-64BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3261487","version":"1","preferredName":"Minimum Immunohistochemistry Staining Method Intensity Score","preferredDefinition":"The smallest possible quantity._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._The degree or magnitude of strength, energy, or feeling._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"3261487v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3261486","version":"1","preferredName":"Minimum Immunohistochemistry Staining Method Intensity Score","preferredDefinition":"The smallest possible quantity.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:The degree or magnitude of strength, energy, or feeling.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25570:C23020:C25539:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-02A0-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"ONEDATA","dateModified":"2011-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-02B1-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"COOPERM","dateModified":"2011-08-16","changeDescription":"Released per approval by T.Lichtenberg. mc 8/16/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If PR IHC intensity is consid","type":"Preferred Question Text","description":"If PR IHC intensity is considered, what is the cut off for positive?","url":null,"context":"NCIP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"What was the cutoff percentage used to determine positivity for PR status?","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DDA2-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-11","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per TCGA approval by T.Lichtenberg. mc 8/16/11 Classified to CDDP/CTSP - smt 12/21/16. 3/24/2017 added alt question text for CTSP task, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}